Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001558497 | SCV000556356 | likely benign | not provided | 2024-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565476 | SCV000671527 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001558497 | SCV001780454 | uncertain significance | not provided | 2023-07-25 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on splicing |
Sema4, |
RCV000565476 | SCV002536888 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-10 | criteria provided, single submitter | curation |